Connect with us

Technology

Today’s Best Deals: LG OLED TVs, Roku 4K Streamers, Xbox Game Pass, and More

Avatar

Published

on

Enlarge (credit: Ars Technica)

The Dealmaster has finished reading Ars’ mammoth macOS 12 review, which means the time has come for another roundup of the best tech deals we could find from across the web.

Today’s rundown is headlined by a few notable discounts on LG’s line of C1 OLED TVs, as both the 48- and 55-inch models are down to new lows of $1,100 and $1,300, respectively, at various retailers. Both deals are about $200 off the usual prices we’ve seen online since the C1 launched earlier this year. They join a roughly $300 discount on the 65-inch model that first arose toward the end of September, also marking the lowest price we’ve tracked.

The C1 is more or less the flagship model in LG’s current line of OLED TVs, as it generally offers the best mix of price and performance. We don’t typically review TVs at Ars, but like most of its OLED predecessors, the C1 has garnered widely positive reviews for producing stellar picture quality (largely thanks to the super-deep contrast of good OLED panels), smooth motion, wide viewing angles, low input lag, a thin and attractive design, and a user interface in webOS that supports most of the major streaming apps and isn’t a total pain to use. It has gamer-friendly features like four HDMI 2.1 inputs and variable refresh rate support, and it works with all of the most commonly used HDR standards.

Read 5 remaining paragraphs | Comments

Source: arstechnica.com

Technology

Truist Sees 350% Upside on This Cancer-Focused Biopharma Stock – Read Why

Avatar

Published

on

Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside.
Analyst Srikripa Devarakonda notes that trading at about 2-times cash, the stock is “undervalued” given its programs in two cancers.
Devarakonda adds that the Verastem base case is supported by a $470 million unadjusted U.S. opportunity in the ovarian cancer program, “early but strong” clinical data, and positive expert feedback.
Related: 

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Technology

“Peek Performance”: Apple’s Next Hardware Event Happens on March 8

Avatar

Published

on

Enlarge (credit: Apple)

Apple will stream its next hardware event to the masses on March 8 at 10 am Pacific (1 pm Eastern), the company announced today. Invitations have already been sent to the press—though the event will be yet another prerecorded, streaming-only presentation with no media in attendance. Apple marketing SVP Greg Joswiak tweeted the now-customary Apple-logo-centric teaser video that doesn’t actually tease anything.

We never know exactly what will be announced at any given Apple event, but Bloomberg’s Mark Gurman reports that the lineup will include a refresh of the budget-friendly iPhone SE and the first iPad Air update in a little over a year.

Rumors have also circulated about updated designs and new Apple Silicon chips for the MacBook Air and the 13-inch MacBook Pro, and the high-end Intel Mac Mini, the 27-inch iMac, and the Mac Pro are all still running Intel chips. The characteristically cryptic “peek performance” tagline does at least hint at new chips for one or more Macs, whether that’s a truly next-gen Apple M2 for thin-and-light laptops or an M1 Pro/Max-focused refresh for the more powerful desktops.

Read 1 remaining paragraphs | Comments

Original Article: arstechnica.com

Continue Reading

Technology

Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

Avatar

Published

on

Charles River Laboratories International Inc’s (NYSE: CRLQ4 sales increased 14.4% Y/Y to $905.1 million, beating the consensus of $888.27 million.

Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments. 
Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and …

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Trending

WOC.io